Effects of the P2‐purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5′‐diphosphate

No abstract is available for this paper.

• Publication year

  1992

• Venue

  British Journal of Pharmacology

• Publication date

  1992-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.1992.tb14274.xPMID 1559134PMCID PMC1908649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Pharmacological receptors on blood platelets.

  1991cited by this paper
• Selective and competitive antagonism by suramin of ATP‐stimulated catecholamine‐secretion from PC12 phaeochromocytoma cells

  1991cited by this paper
• Aggregin: a platelet ADP receptor that mediates activation

  1990cited by this paper
• Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP

  1990cited by this paper
• Suramin is a slowly‐equilibrating but competitive antagonist at P2x‐receptors in the rabbit isolated ear artery

  1990cited by this paper
• Reversible and selective antagonism by suramin of ATP‐activated inward current in PC12 phaeochromocytoma cells

  1990cited by this paper
• Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes.

  1990cited by this paper
• Suramin antagonizes responses to P2‐purinoceptor agonists and purinergic nerve stimulation in the guinea‐pig urinary bladder and taenia coli

  1990cited by this paper
• P2-purinoceptor-activated membrane currents and inositol tetrakisphosphate formation are blocked by suramin.

  1990cited by this paper
• Subtypes of P2‐Purinoceptors

  1990cited by this paper
• Suramin and the inhibitory junction potential in taenia caeci of the guinea-pig.

  1989cited by this paper
• The inhibitory action of suramin on the P2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeci.

  1989cited by this paper
• The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder.

  1989cited by this paper
• Inhibition of vacuolar H+‐ATPases by fusidic acid and suramin

  1988cited by this paper
• Duck hepatitis B virus: DNA polymerase and reverse transcriptase activities of replicative complexes isolated from liver and their inhibition in vitro.

  1988cited by this paper
• Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteins.

  1988cited by this paper
• Inhibition by suramin of mitochondrial ATP synthesis.

  1988cited by this paper
• Suramin: a reversible P2‐purinoceptor antagonist in the mouse vas deferens

  1988cited by this paper
• Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin.

  1988cited by this paper
• A Pharmacologic Analysis of Drug-Receptor Interaction

  1987cited by this paper
• Extracellular ATP: effects, sources and fate.

  1986cited by this paper
• Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection

  1986cited by this paper
• Is there a basis for distinguishing two types of P2-purinoceptor?

  1985cited by this paper
• Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

  1985cited by this paper
• 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.

  1983cited by this paper
• Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.

  1982cited by this paper
• ADENOSINE 5′‐DIPHOSPHATE ANTAGONISTS AND HUMAN PLATELETS: NO EVIDENCE THAT AGGREGATION AND INHIBITION OF STIMULATED ADENYLATE CYCLASE ARE MEDIATED BY DIFFERENT RECEPTORS

  1982cited by this paper
• Identification of two distinct adenosine diphosphate receptors in human platelets.

  1980cited by this paper
• Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump.

  1973cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper
• Studies on suramin; the action of the drug on some enzymes.

  1950cited by this paper

• Purinergic inhibitory regulation of esophageal smooth muscle is mediated by P2Y receptors and ATP-dependent potassium channels in rats

  2024cites this paper
• Embryos assist morphogenesis of others through calcium and ATP signaling mechanisms in collective teratogen resistance

  2024cites this paper
• Binding of adenosine derivatives to carrier proteins may reduce their antiplatelet activity.

  2020cites this paper
• VI. Nomenclature and Classification of Purinoceptors *

  2016cites this paper
• Blood cells: an historical account of the roles of purinergic signalling

  2015cites this paper
• Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells

  2013cites this paper
• adenosine diphosphate in platelets and megakaryocytic cells Novel structurally altered P2X1 receptor is preferentially activated by

  2013cites this paper
• Hyposmotic stress causes ATP release and stimulates Na,K‐ATPase activity in porcine lens

  2011cites this paper
• Changes in adenosine triphosphate-stimulated ATP release suggest association between cytokine and purinergic signaling in bladder urothelial cells.

  2009cites this paper
• P2Y2 receptor-mediated Ca2+ signaling and spontaneous Ca2+ releases in human valvular myofibroblasts.

  2008cites this paper
• Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis.

  2006cites this paper
• The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range

  2005cites this paper
• Pharmacological approaches to studying platelet function: an overview.

  2004cites this paper
• P2Y‐mediated Ca2+ response is spatiotemporally graded and synchronized in sensory neurons: a two‐photon photolysis study

  2004cites this paper
• Role of adenine nucleotides in insulin secretion from MIN6 pseudoislets.

  2002cites this paper
• Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.

  2002cites this paper
• Cell-culture propagation of porcine enteric calicivirus mediated by intestinal contents is dependent on the cyclic AMP signaling pathway.

  2002cites this paper
• P2Y receptor regulation of mitogenesis in vascular smooth muscle cells

  2002cites this paper
• P1 and P2 Receptors in Platelets

  2001cites this paper
• Discovery and recognition of purine receptor subtypes on platelets

  2001cites this paper
• Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells.

  2001cites this paper
• ADP can induce aggregation of human platelets via both P2Y1 and P2T receptors

  2000cites this paper
• A pharmacological characterization of ADP receptors on human platelets

  2000influential citation
• Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications

  2000cites this paper
• Potassium-current oscillation of rat megakaryocytes: As a model system for drug evaluation (Review).

  1999cites this paper
• The Gene, ialA, Associated with the Invasion of Human Erythrocytes by Bartonella bacilliformis, Designates a Nudix Hydrolase Active on Dinucleoside 5′-Polyphosphates*

  1999cites this paper
• Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5′‐diphosphate (ADP) in human platelets

  1999cites this paper
• ATP‐evoked increases in [Ca2+]i and peptide release from rat isolated neurohypophysial terminals via a P2X2 purinoceptor

  1998cites this paper
• Physiological Roles for P2 Receptors in Platelets, Visceral Smooth Muscle, and the Immune and Endocrine Systems

  1998cites this paper
• Effects of adenosine 3′‐phosphate 5′‐phosphosulfate on P2 receptors in platelets and smooth muscle preparations

  1998cites this paper
• Receptors for purines and pyrimidines.

  1998cites this paper
• Effects of suramin on human platelet aggregation and Ca2+ mobilization induced by thrombin and other agonists.

  1998cites this paper
• Dual effects of extracellular ATP on the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.

  1997cites this paper
• Purinoceptors in neuromuscular transmission.

  1997cites this paper
• Activation of ADP Receptors and Platelet Function

  1997cites this paper
• Purinergic receptors on blood platelets.

  1996cites this paper
• Probenecid Inhibits Platelet Responses to Aggregating Agents in Vitro and Has a Synergistic Inhibitory Effect with Penicillin G

  1996cites this paper
• ATP induces release of newly synthesized dopamine in the rat striatum.

  1996cites this paper
• P2 purinoceptors: historical perspective and classification.

  1996cites this paper
• ADP Receptors on Platelets

  1996cites this paper
• Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli

  1996cites this paper
• Purinoceptors: From History to Recent Progress. A Review

  1996cites this paper
• P2 Purinoceptors: Historical Perspective and Classification

  1996cites this paper
• Effects of 2‐methylthioadenosine 5′‐β,γ‐methylenetriphosphonate and 2‐ethylthioadenosine 5′‐monophosphate on human platelet activation induced by adenosine 5′‐diphosphate

  1996cites this paper
• P2T purinoceptors: ADP receptors on platelets.

  1996cites this paper
• Design and pharmacological characterization of selective P2-purinoceptor antagonists

  1996cites this paper
• ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum.

  1995cites this paper
• Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation.

  1995cites this paper
• Nucleotides as Extracellular Signalling Molecules

  1995cites this paper
• Effects of suramin on contractions of the guinea‐pig vas deferens induced by analogues of adenosine 5′‐triphosphate

  1995cites this paper
• Effects ofsuramin on contractions oftheguinea-pig vas deferens induced byanalogues ofadenosine 5'-triphosphate

  1995cites this paper
• Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*)

  1995cites this paper
• Nomenclature and classification of purinoceptors.

  1994cites this paper
• P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens

  1994cites this paper
• Activation of P2-purinoceptors in the nucleus tractus solitarius mediate depressor responses.

  1994cites this paper
• ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.

  1994cites this paper
• Priming of the respiratory burst of human neutrophils by the diadenosine polyphosphates, AP4A and AP3A: role of intracellular calcium.

  1994cites this paper
• Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate.

  1994cites this paper
• Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.

  1994cites this paper
• Suramin inhibits intimal thickening following intimal injury in the rabbit aorta in vivo.

  1994cites this paper
• Differential effects of suramin on P2‐purinoceptors mediating contraction of the guinea‐pig vas deferens and urinary bladder

  1994cites this paper
• PHARMACOLOGICAL ACTIONS OF THE COENZYMES NAD(H) AND NADP(H) ON THE RAT ANOCOCCYGEUS MUSCLE

  1994cites this paper
• Receptors for ADP on human blood platelets.

  1994cites this paper
• Suramin and reactive blue 2 are antagonists for a newly identified purinoceptor on rat megakaryocyte

  1994cites this paper
• Suramin andreactive blue2are antagonists fora newly identified purinoceptor on ratmegakaryocyte

  1994cites this paper
• FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T‐purinoceptors

  1994cites this paper
• Dual contractile effects of ATP released by field stimulation revealed by effects of α,β‐methylene ATP and suramin in rat tail artery

  1993cites this paper
• P2 receptor: Subclassification and structure‐activity relationships

  1993cites this paper
• Activation of the phospholipase C pathway by ATP is mediated exclusively through nucleotide type P2‐purinoceptors in C2C12 myotubes

  1993cites this paper
• Dual contractile effects of ATP released by field stimulation revealed by effects of alpha,beta-methylene ATP and suramin in rat tail artery.

  1993cites this paper
• Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1‐ and P2‐purinoceptors

  1993cites this paper
• Activation ofthephospholipase Cpathway byATPis mediated exclusively through nucleotide typeP2-purinoceptors inC2C12myotubes

  1993cites this paper
• Tsetse and Trypanosomiasis Information Quarterly 15 ( 4 ) financially : there is a good possibility of reinvasion in cleared areas

  year unknowncites this paper